Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Lleo

Showing results (141-150 of 202) with videos related to

Pageof 21
Sort By:
Expert Opinion on Drug Safety|April 21, 2021
Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life studyNicola Pugliese, Alessia Giorgini, Daniela Maggi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 27, 2023
Filamin A is involved in human intrahepatic cholangiocarcinoma aggressiveness and progressionEleonora Vitali, Barbara Franceschini, Flavio Milana, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2020
COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, ItalyAlessio Aghemo, Daniele Piovani, Tommaso Lorenzo Parigi, et al.
Hepatology (Baltimore, Md.)|January 29, 2011
B cell depletion therapy exacerbates murine primary biliary cirrhosisAmy Dhirapong, Ana Lleo, Guo-Xiang Yang, et al.
JHEP Reports : Innovation in Hepatology|March 27, 2025
Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasisAngelo Di Giorgio, Marco Sciveres, Maurizio Fuoti, et al.
Current Oncology (Toronto, Ont.)|November 24, 2022
Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360)Tiziana Comito, Mauro Loi, Ciro Franzese, et al.
Cancers|November 27, 2021
Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint InhibitorsNicola Personeni, Tiziana Pressiani, Antonio D'Alessio, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 23, 2011
Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma: its synthesis is reduced favoring cholangiocarcinoma growthYuyan Han, Sharon Demorrow, Pietro Invernizzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 30, 2024
The tumor microenvironment of VETC+ hepatocellular carcinoma is enriched of immunosuppressive TAMs spatially close to endothelial cellsCamilla De Carlo, Roy Rosman-Nathanson, Barbara Durante, et al.
Clinical Epigenetics|July 8, 2015
DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosisAna Lleo, Weici Zhang, Ming Zhao, et al.
Pageof 21

Showing results (141-150 of 202) with videos related to

Sort By:
Pageof 21
Expert Opinion on Drug Safety|April 21, 2021
Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life studyNicola Pugliese, Alessia Giorgini, Daniela Maggi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 27, 2023
Filamin A is involved in human intrahepatic cholangiocarcinoma aggressiveness and progressionEleonora Vitali, Barbara Franceschini, Flavio Milana, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2020
COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, ItalyAlessio Aghemo, Daniele Piovani, Tommaso Lorenzo Parigi, et al.
Hepatology (Baltimore, Md.)|January 29, 2011
B cell depletion therapy exacerbates murine primary biliary cirrhosisAmy Dhirapong, Ana Lleo, Guo-Xiang Yang, et al.
JHEP Reports : Innovation in Hepatology|March 27, 2025
Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasisAngelo Di Giorgio, Marco Sciveres, Maurizio Fuoti, et al.
Current Oncology (Toronto, Ont.)|November 24, 2022
Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360)Tiziana Comito, Mauro Loi, Ciro Franzese, et al.
Cancers|November 27, 2021
Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint InhibitorsNicola Personeni, Tiziana Pressiani, Antonio D'Alessio, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 23, 2011
Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma: its synthesis is reduced favoring cholangiocarcinoma growthYuyan Han, Sharon Demorrow, Pietro Invernizzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 30, 2024
The tumor microenvironment of VETC+ hepatocellular carcinoma is enriched of immunosuppressive TAMs spatially close to endothelial cellsCamilla De Carlo, Roy Rosman-Nathanson, Barbara Durante, et al.
Clinical Epigenetics|July 8, 2015
DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosisAna Lleo, Weici Zhang, Ming Zhao, et al.
Pageof 21